NCT06525727

Brief Summary

Although falls are the most important cause of intracranial hemorrhage in the population over 65, studies have shown that bleeding occurs in only 5% of geriatric patients who fall. Guidelines have been developed to assist the clinician in identifying patients at risk of intracranial hemorrhage due to the relatively low incidence but significant morbidity and mortality. The 'Falls Decision Rule' was developed by de Wit et al. in 2023 to assess the need for CT in this patient group. In this study, external validation of this newly developed score was planned to evaluate its safety, applicability, and authenticity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 24, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 29, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 12, 2024

Completed
9 months until next milestone

Results Posted

Study results publicly available

July 30, 2025

Completed
Last Updated

January 22, 2026

Status Verified

January 1, 2026

Enrollment Period

9 months

First QC Date

July 24, 2024

Results QC Date

February 16, 2025

Last Update Submit

January 4, 2026

Conditions

Keywords

Falls Rulegeriatricruleexternal validation

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With the Clinically Important Intracranial Bleeding

    The primary outcome is 'clinically significant intracranial hemorrhage' identified within 42 days following the initial presentation in the emergency department. 'Clinically significant intracranial hemorrhage' is defined as hemorrhage within the cranial vault, encompassing subdural, intracerebral, intraventricular, subarachnoid, epidural hemorrhage, and cerebral contusion, necessitating medical or surgical intervention. Medical intervention is defined as any of the following actions: temporary or permanent cessation of anticoagulant or antiplatelet medications; administration of an antifibrinolytic agent; reversal of anticoagulation; or hospitalization for neurological monitoring. These criteria align with those established in the original study.

    From baseline to 42 days (Patients will be followed up for 42 days after the fall and evaluated for delayed intracranial haemorrhage).

Secondary Outcomes (2)

  • Number of Participant With Neurosurgical Intervention

    42 day

  • Number of Patients With Mortality

    42 day

Study Arms (1)

Patients aged 65 years and over

Patients aged 65 years and over who came to the emergency department with a fall on level ground ((either inside or outside), off a chair, toilet seat or out of bed) within the last 48 hours

Other: Falls Decision Rule

Interventions

The Falls Decision Rule is a rule used to assess the risk of intracranial haemorrhage in geriatric patients and to prevent brain tomography (CT) in low-risk patients. This rule recommends that brain CT is not necessary in patients who do not have significant head trauma, memory loss, newly developing neurological examination disorder, or frailty score lower than 5 after a fall.

Patients aged 65 years and over

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population consists of geriatric patients aged 65 years and older who present to the emergency department within 48 hours of experiencing a fall on level ground ((either inside or outside), off a chair, toilet seat, or out of bed). These patients will be included if they provide informed consent or if their legal guardians provide consent if the patients are unable to do so. The study aims to externally validate the Falls Decision Rule to exclude intracranial bleeding in this specific population. All patients meeting the inclusion criteria and none of the exclusion criteria will be enrolled in the study, and they will be observed for clinically significant intracranial bleeding for up to 42 days post-fall.

You may qualify if:

  • Patients aged 65 years and older.
  • Patients who presented to the emergency department within 48 hours of a fall.
  • Patients who provided informed consent to participate in the study or whose legal guardians provided consent if the patients are unable to do so.

You may not qualify if:

  • Patients who have already been included in the study previously.
  • Patients who refuse medical treatment or withdraw consent during the study period.
  • Patients with incomplete data necessary for the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University Pendik Training and Research Hospital

Istanbul, Pendik, Turkey (Türkiye)

Location

Related Publications (2)

  • Gray I, de Wit K. Fast-tracking falls - expediting emergency care with evidence. CJEM. 2025 Aug;27(8):580-581. doi: 10.1007/s43678-025-00970-x. No abstract available.

  • Kudu E, Altun M, Danis F, Karacabey S, Sanri E, Denizbasi A. Validating the falls decision rule: optimizing head CT use in older adults with ground-level falls. CJEM. 2025 Aug;27(8):629-637. doi: 10.1007/s43678-025-00937-y. Epub 2025 May 13.

MeSH Terms

Conditions

Intracranial Hemorrhages

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Limitations and Caveats

This study has limitations, primarily its single-center design, which may limit generalizability. However, as an external validation study, the findings suggest applicability to broader populations. Variability in physician judgment on CT use is another limitation, despite standardized training. Not all patients underwent CT at the initial visit, posing a risk of missed CIIB. However, a 42-day follow-up ensured comprehensive assessment, with no patients lost to follow-up.

Results Point of Contact

Title
Dr. Emre Kudu
Organization
Marmara University School of Medicine

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

July 24, 2024

First Posted

July 29, 2024

Study Start

January 20, 2024

Primary Completion

October 1, 2024

Study Completion

November 12, 2024

Last Updated

January 22, 2026

Results First Posted

July 30, 2025

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations